Inflammatory status upregulated in first-episode schizophrenia
Patients with first-episode schizophrenia exhibit upregulation of key proinflammatory molecules, study findings show. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 28, 2013 Category: Psychiatry Source Type: news
Negative symptoms ‘key to recovery’ in first-episode psychosis
The severity of negative symptoms in people with first-episode psychosis is a strong determinant of subsequent recovery, a long-term study has shown. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 27, 2013 Category: Psychiatry Source Type: news
Glutamate role in schizophrenia likely
The possible role of glutamate in schizophrenia is strengthened by a study showing normalized levels after successful antipsychotic treatment in patients with first-episode psychosis. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 23, 2013 Category: Psychiatry Source Type: news
Glial cell contribution to schizophrenia refined
An analysis of functional gene sets has helped to define the role of glial cells in schizophrenia. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 22, 2013 Category: Psychiatry Source Type: news
Integrated therapy has few long-term schizophrenia benefits
The benefits of early integrated treatment for recent onset schizophrenia may not be sustained over the long term, findings from a 12-year follow-up study show. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 21, 2013 Category: Psychiatry Source Type: news
Gyrification unfolds psychosis treatment response
A study assessing cortical folding, or gyrification, offers a way to predict which patients with first-episode psychosis will respond to treatment with antipsychotics. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 20, 2013 Category: Psychiatry Source Type: news
Blood profiling could guide schizophrenia treatment
Patients with schizophrenia can be categorized into two distinct subcategories based on their blood molecular profiles, say researchers. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 16, 2013 Category: Psychiatry Source Type: news
Smoking cessation a priority in schizophrenia
Smoking is a major driver of death by natural causes among patients with schizophrenia, report researchers. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 15, 2013 Category: Psychiatry Source Type: news
Stable traits dominate psychosis risk
Researchers have found that variability in psychotic symptom expression is largely caused by stable traits. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 14, 2013 Category: Psychiatry Source Type: news
Cognitive impairment in schizophrenia a global problem
Cognitive impairment in patients with schizophrenia is still as substantial and generalized in its effects as it has ever been, despite improvements in how it is diagnosed and assessed, a review of the literature suggests. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 13, 2013 Category: Psychiatry Source Type: news
Psychosis prodrome rarely converts to psychotic illness
Just one in four people considered at clinical high risk for psychosis will develop overt psychosis within 2 years, a meta-analysis has found. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 9, 2013 Category: Psychiatry Source Type: news
Treatment targets identified in first-episode psychosis
Addressing multiple substance use disorder should be a key aim of treatment in people with a first episode of psychosis who report substance use, Australian researchers say. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 8, 2013 Category: Psychiatry Source Type: news
Study traces natural history of first-episode psychosis
Around one in five adults who experience a first psychotic episode will subsequently be diagnosed with schizophrenia, and one in 20 will be diagnosed with bipolar disorder, a 5-year follow-up study has found. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 6, 2013 Category: Psychiatry Source Type: news
Intermittent antipsychotic therapy ‘not supported by evidence’
Intermittent antipsychotic therapy is less effective than continuous maintained therapy for preventing relapse in people with schizophrenia, conclude the authors of a Cochrane review. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 6, 2013 Category: Psychiatry Source Type: news
Negative schizophrenia symptoms worthy treatment target
Targeting either prominent positive or negative symptoms when treating patients with schizophrenia could significantly improve their health-related quality of life, a CATIE analysis suggests. (Source: MedWire News - Schizophrenia)
Source: MedWire News - Schizophrenia - August 2, 2013 Category: Psychiatry Source Type: news
